Compare Heron Therapeutics Inc (HRTX) vs United Airlines Holdings Inc (UAL) Price & Performance

Heron Therapeutics IncTrade

United Airlines Holdings IncTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs United Airlines Holdings Inc — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while United Airlines Holdings Inc trades at $117.98 (market cap $38.15B). The key difference: United Airlines Holdings Inc is far larger — about 417.1× Heron Therapeutics Inc's market cap, and United Airlines Holdings Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

	HRTX	UAL
Market Cap	$91.46M	$38.15B
Sector	Health	Industrials
52-Week High	$1.96	$136.11
52-Week Low	$0.39	$84.57
Enterprise Value	$189.36M	$55.18B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.

Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.

United Airlines Holdings Inc

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HRTX

View details →

UAL

Jefferies keeps Buy on United Airlines despite fuel cost pressures, lowers price target to $155.Alex Lavoie · 2 days agoBullish United Airlines Q2 revenue hits record $17.7B despite rising fuel costs, with strong profit outlook.Seeking Alpha · 4 days agoBullish Morgan Stanley raises United Airlines price target to $190, citing strong recovery despite fuel cost challenges.Rayan Ahmad · 4 days agoBullish View details →

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

About United Airlines Holdings Inc

United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.